Linked from

The 66 pages that link to Gene therapy, each with the reason it gives.

• Wiskott–Aldrich syndromeRelated: Clinical approaches aim to restore WAS gene function in a patient's blood-forming cells.

• MedicineBroader topic: It can target disease by changing gene function in cells.

• ProgeriaRelated: A lasting therapy might reduce abnormal LMNA expression, but delivery and long-term safety remain challenges.

• Antisense therapyCompared with: Antisense therapy usually acts on RNA transiently rather than permanently changing genomic DNA.

• CureRelated: Correcting or replacing a disease-causing gene can target an underlying cause.

• Metabolic disorderRelated: It offers a way to target some inherited causes of metabolic disease.

• MicrophthalmiaCompared with: It is not an established way to restore an eye that failed to develop normally.

• Barth syndromeRelated: Correcting TAZ function is a research direction, not an established treatment for Barth syndrome.

• History of genetic engineeringRelated: Genetic engineering enabled therapies that alter patient cells to address disease.

• Molecular medicineRelated: It applies molecular understanding directly by changing disease-related genetic instructions.

• NucleofectionRelated: Nucleofection is a laboratory delivery technique relevant to ex vivo cell engineering, not itself a therapy.

• Oculocerebrorenal syndromeRelated: Correcting OCRL function is a potential research direction, but delivery to multiple affected tissues remains challenging.

• Regulation of gene expressionRelated: Therapies can aim to restore, suppress, or tune the expression of particular genes.

• Sanfilippo syndromeRelated: Investigational approaches aim to restore the missing enzyme and reduce substrate accumulation.

• Stargardt diseaseRelated: ABCA4-based approaches are under investigation, but no established gene therapy cures Stargardt disease.

• Stickler syndromeRelated: No established gene therapy currently corrects the underlying collagen defects in Stickler syndrome.